- Home
- PAYC vs PCVX Comparison
PAYC vs PCVX Comparison
Compare PAYC & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAYC
- PCVX
- Stock Information
- Founded
- PAYC 1998
- PCVX 2013
- Country
- PAYC United States
- PCVX United States
- Employees
- PAYC N/A
- PCVX N/A
- Industry
- PAYC Computer Software: Prepackaged Software
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- PAYC Technology
- PCVX Health Care
- Exchange
- PAYC Nasdaq
- PCVX Nasdaq
- Market Cap
- PAYC 12.8B
- PCVX 4.0B
- IPO Year
- PAYC 2014
- PCVX 2020
- Fundamental
- Price
- PAYC $214.82
- PCVX $30.89
- Analyst Decision
- PAYC Hold
- PCVX Strong Buy
- Analyst Count
- PAYC 12
- PCVX 8
- Target Price
- PAYC $239.36
- PCVX $114.17
- AVG Volume (30 Days)
- PAYC 571.7K
- PCVX 1.6M
- Earning Date
- PAYC 10-29-2025
- PCVX 11-04-2025
- Dividend Yield
- PAYC 0.70%
- PCVX N/A
- EPS Growth
- PAYC N/A
- PCVX N/A
- EPS
- PAYC 7.40
- PCVX N/A
- Revenue
- PAYC $1,959,900,000.00
- PCVX N/A
- Revenue This Year
- PAYC $10.98
- PCVX N/A
- Revenue Next Year
- PAYC $9.14
- PCVX N/A
- P/E Ratio
- PAYC $29.06
- PCVX N/A
- Revenue Growth
- PAYC 10.21
- PCVX N/A
- 52 Week Low
- PAYC $158.03
- PCVX $27.66
- 52 Week High
- PAYC $267.76
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- PAYC 39.97
- PCVX 43.22
- Support Level
- PAYC $210.51
- PCVX $31.47
- Resistance Level
- PAYC $227.49
- PCVX $33.32
- Average True Range (ATR)
- PAYC 5.05
- PCVX 1.34
- MACD
- PAYC -0.87
- PCVX -0.00
- Stochastic Oscillator
- PAYC 24.46
- PCVX 16.87
About PAYC Paycom Software Inc.
Founded in 1998, Paycom is a human capital management software-as-a-service provider addressing customer requirements surrounding payroll, talent acquisition, talent management, HR management, as well as time and labor. The company primarily services midsize businesses within the United States, targeting businesses with 50-10,000 employees. The company primarily generates revenue through the sale of subscriptions providing access to its HCM platform. To a lesser extent, the company also generates revenue from implementation services provided to customers as well as interest income generated from customer funds. As of fiscal 2024, the company serviced slightly over 37,500 customers and stored data on over 7 million employees.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.